Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorKardium Inc.

About this trial

This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).

Patients with a planned ablation procedure using the commercially available Globe PF System

Patients whose life expectancy is 1 year or less

Contraindication to left atrial catheter ablation or PF ablation

Current enrollment in any investigational study of a medical device, biologic, or drug not pre-approved by Kardium

500 Participants

are divided into 1 treatment group

This trial has no locations

Kardium Inc.

Lead sponsor